1. Home
  2. LGND vs HI Comparison

LGND vs HI Comparison

Compare LGND & HI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • HI
  • Stock Information
  • Founded
  • LGND 1987
  • HI 2007
  • Country
  • LGND United States
  • HI United States
  • Employees
  • LGND N/A
  • HI N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • HI Miscellaneous manufacturing industries
  • Sector
  • LGND Health Care
  • HI Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • HI Nasdaq
  • Market Cap
  • LGND 2.2B
  • HI 2.3B
  • IPO Year
  • LGND 1992
  • HI N/A
  • Fundamental
  • Price
  • LGND $120.67
  • HI $30.90
  • Analyst Decision
  • LGND Strong Buy
  • HI Buy
  • Analyst Count
  • LGND 6
  • HI 2
  • Target Price
  • LGND $145.00
  • HI $36.50
  • AVG Volume (30 Days)
  • LGND 79.6K
  • HI 509.7K
  • Earning Date
  • LGND 02-27-2025
  • HI 02-05-2025
  • Dividend Yield
  • LGND N/A
  • HI 2.89%
  • EPS Growth
  • LGND 160.46
  • HI N/A
  • EPS
  • LGND 2.47
  • HI N/A
  • Revenue
  • LGND $152,422,000.00
  • HI $3,116,400,000.00
  • Revenue This Year
  • LGND $26.86
  • HI N/A
  • Revenue Next Year
  • LGND $14.95
  • HI $4.10
  • P/E Ratio
  • LGND $48.82
  • HI N/A
  • Revenue Growth
  • LGND N/A
  • HI 5.87
  • 52 Week Low
  • LGND $67.72
  • HI $25.11
  • 52 Week High
  • LGND $129.90
  • HI $50.58
  • Technical
  • Relative Strength Index (RSI)
  • LGND 59.36
  • HI 39.25
  • Support Level
  • LGND $110.42
  • HI $29.05
  • Resistance Level
  • LGND $119.26
  • HI $35.48
  • Average True Range (ATR)
  • LGND 3.82
  • HI 1.38
  • MACD
  • LGND 0.61
  • HI -0.27
  • Stochastic Oscillator
  • LGND 81.35
  • HI 28.69

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About HI Hillenbrand Inc

Hillenbrand Inc is a U.S.-based company that operates through three segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment. The Molding Technology Solutions segment offers engineered and customized systems in plastic technology and processing. Batesville designs provides, and markets funeral services and solutions.

Share on Social Networks: